We are live on ! Find out more
DCP

Distillate Capital Partners Portfolio holdings

AUM $1.92B
1-Year Est. Return 5.31%
This Fund
S&P 500
This Quarter Est. Return
-1.39%
1 Year Est. Return
-5.31%
3 Year Est. Return
+9.94%
5 Year Est. Return
+39.07%
10 Year Est. Return
–
AUM
$1.92B
AUM Growth
+$24.9M
Cap. Flow
+$95.9M
Cap. Flow %
4.98%
Top 10 Hldgs %
18.61%
Holding
145
New
27
Increased
46
Reduced
44
Closed
27

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$28.6M
2
ICE icon
Intercontinental Exchange
ICE
+$28.1M
3
INTU icon
Intuit
INTU
+$28M
4
FDX icon
FedEx
FDX
+$25.3M
5
BSX icon
Boston Scientific
BSX
+$24.5M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$32.7M
2
ABBV icon
AbbVie
ABBV
+$22.7M
3
PCAR icon
PACCAR
PCAR
+$20.5M
4
CTRA
Coterra Energy
CTRA
+$20.1M
5
EME icon
Emcor
EME
+$18.9M

Sector Composition

Rank Sector Weight
1 Technology 27.14%
2 Healthcare 22.82%
3 Industrials 12.35%
4 Consumer Discretionary 11.36%
5 Financials 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPAY icon
76
Corpay
CPAY
$26.5B
$14.7M 0.77%
44,174
+1,992
+5% +$662K
UTHR icon
77
United Therapeutics
UTHR
$21.3B
$14.6M 0.76%
+26,967
New +$15.2M
TTC icon
78
Toro Company
TTC
$8.73B
$14.6M 0.76%
149,499
-4,091
-3% -$380K
BLD
79
DELISTED
TopBuild
BLD
$14.4M 0.75%
40,552
-1,117
-3% -$461K
DOCU
80
DocuSign
DOCU
$13.2B
$14.4M 0.75%
323,122
+18,910
+6% +$886K
ZM icon
81
Zoom
ZM
$26.9B
$14.3M 0.75%
166,188
+4,097
+3% +$387K
COR icon
82
Cencora
COR
$59B
$14.3M 0.75%
50,641
-937
-2% -$270K
ALLE icon
83
Allegion
ALLE
$13.1B
$14.2M 0.74%
101,420
-2,061
-2% -$280K
BMRN icon
84
BioMarin Pharmaceuticals
BMRN
$12.6B
$14.2M 0.74%
+248,916
New +$13.6M
BWA icon
85
BorgWarner
BWA
$13B
$13.8M 0.72%
207,304
-101,988
-33% -$6.46M
CCK icon
86
Crown Holdings
CCK
$12B
$13.5M 0.7%
120,566
+2,732
+2% +$276K
ALGN icon
87
Align Technology
ALGN
$10.6B
$13.4M 0.7%
79,557
-30,216
-28% -$5.24M
AYI icon
88
Acuity Brands
AYI
$8.97B
$13.4M 0.7%
35,572
-5,882
-14% -$1.74M
LKQ icon
89
LKQ Corp
LKQ
$6.03B
$13.1M 0.68%
496,798
-12,104
-2% -$336K
RMD icon
90
ResMed
RMD
$33B
$12.9M 0.67%
66,399
-950
-1% -$197K
DBX icon
91
Dropbox
DBX
$8.18B
$12.6M 0.66%
459,965
+23,698
+5% +$609K
IT icon
92
Gartner
IT
$11.9B
$12.6M 0.65%
96,994
+2,564
+3% +$386K
BR icon
93
Broadridge
BR
$18.7B
$12.6M 0.65%
91,721
+3,317
+4% +$501K
NVR icon
94
NVR
NVR
$16.6B
$12.5M 0.65%
1,840
-18
-1% -$114K
RGLD icon
95
Royal Gold
RGLD
$21.3B
$12.3M 0.64%
61,841
-803
-1% -$187K
AVY icon
96
Avery Dennison
AVY
$13B
$12M 0.62%
73,680
+1,112
+2% +$181K
DOX icon
97
Amdocs
DOX
$6.32B
$11.9M 0.62%
235,736
+9,904
+4% +$607K
DECK icon
98
Deckers Outdoor
DECK
$10.9B
$11.8M 0.62%
119,261
+3,951
+3% +$416K
AOS icon
99
A.O. Smith
AOS
$7.74B
$11.7M 0.61%
186,886
-1,006
-0.5% -$61K
UHS icon
100
Universal Health Services
UHS
$10.7B
$11.5M 0.6%
77,035
+2,257
+3% +$367K
2 3
4
5 6

Similar funds

SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return

Distillate Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Distillate Capital Partners held 145 positions worth $1.92B, up 1.3% from $1.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Distillate Capital Partners deployed $95.9M of net new capital in Q2 2026, opening 27 new positions and adding to 46 existing holdings. Its largest new stake was CME Group: 103,554 shares worth $22.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $22.7M trimmed.

  • Distillate Capital Partners's largest Q2 2026 buy was CME Group: 103,554 shares worth $22.9M.
  • Distillate Capital Partners added most to Accenture in Q2 2026, an estimated $21.1M increase.
  • Distillate Capital Partners's biggest Q2 2026 reduction was AbbVie, cutting an estimated $22.7M.
  • Distillate Capital Partners fully exited Qualcomm in Q2 2026, selling an estimated $32.7M.
  • Distillate Capital Partners's ten largest holdings make up 19% of its $1.92B portfolio in Q2 2026.
  • Distillate Capital Partners opened 27 new positions and closed 27 in Q2 2026.
  • Distillate Capital Partners's portfolio value rose 1.3% quarter-over-quarter to $1.92B.

Based on Distillate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.